Clinical Trial Update: GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports safety data and early results for GH21 capsules in patients with advanced solid tumors, including non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• GH21 Capsules (GH21)

Snippet

Sponsor: Suzhou Genhouse Bio Co., Ltd. | Conditions: Advanced Solid Tumor, Non-Small Cell Lung Cancer | Phase 1 | Status: UNKNOWN